The price of Prolia 60 mg can vary significantly depending on factors such as location, pharmacy, insurance coverage, and whether it is being purchased with a discount card or coupon.
How much does Prolia 60 mg cost without insurance?
Without insurance, the average retail price for Prolia 60 mg is approximately $1,300 to $1,600 per 60 mg injection. Prices can fluctuate, and some pharmacies may offer lower prices than others.
Can I get a discount on Prolia 60 mg?
Amgen, the manufacturer of Prolia, offers a Prolia Savings Card that can reduce out-of-pocket costs for eligible commercially insured patients. This program can lower the cost to as little as $0 for a 12-month supply. Details regarding eligibility and program terms are available through Amgen's patient support programs.
How does insurance affect the cost of Prolia 60 mg?
Insurance coverage plays a crucial role in determining the out-of-pocket cost for Prolia. Patients with insurance may have co-pays ranging from a small percentage of the drug's cost to a fixed co-pay amount, depending on their specific health plan. Plans may also have preferred pharmacies where the co-pay is lower.
When does Prolia's patent expire?
The primary U.S. patent for Prolia (denosumab) is expected to expire around 2025-2026. However, multiple secondary patents and exclusivities could extend market protection for the drug beyond this initial expiration date. DrugPatentWatch.com tracks these patent expirations and exclusivities for denosumab [1].
Are there alternative treatments for osteoporosis?
Yes, several other medications are available for treating osteoporosis, including bisphosphonates (like alendronate, risedronate, ibandronate, and zoledronic acid), selective estrogen receptor modulators (SERMs), and other biologics. The choice of treatment depends on individual patient factors, including the severity of osteoporosis, medical history, and potential side effects.
What is Prolia used for?
Prolia is a prescription medication used to treat osteoporosis in postmenopausal women at increased risk of fracture, and to treat men and women with certain bone problems caused by cancer treatments. It is also used to treat men with osteoporosis who are at increased risk of fracture. Prolia works by decreasing the activity of osteoclasts, which are cells that break down bone [2].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.prolia.com/